Eastman Chemical Company
Stock Forecast, Prediction & Price Target
Eastman Chemical Company (EMN) stock Price Target by analysts
$123.33
Potential upside: 84.63%
Eastman Chemical Company price prediction
What is Eastman Chemical Company stock analysts` prediction?
Eastman Chemical Company stock forecast: Based on 3 Wall Street analysts` predicted price targets for Eastman Chemical Company in the last 3 months, the avarage price target is $123.33, with a high forecast of $NaN. The average price target represents a 84.63% change from the last price of $66.8.
Disclaimer: This is not investment advice. Don't use price targets as the only investment indicator. Always remember to do your own thorough research and due diligence before making an investment decision.
Eastman Chemical Company stock Price Target by analysts
Full breakdown of analysts given Eastman Chemical Company price targets
| Analyst name & company | Analyst win rate | Publish date | Price target | Price when posted | Source | Historical targets |
|---|---|---|---|---|---|---|
Aleksey Yefremov KeyBanc | 0% 0/1 | 11 months ago | $121 81.13% upside | $100.05 | StreetInsider | Previous targets (0) |
Steve Byrne Bank of America Securities | 0% 0/2 | 12 months ago | $119 78.14% upside | $110.32 | StreetInsider | Previous targets (1) |
Lawrence Alexander Jefferies | 33.33% 1/3 | about 1 year ago | $130 94.61% upside | $110.58 | StreetInsider | Previous targets (2) |
David Begleiter Deutsche Bank | 0% 0/1 | about 1 year ago | $108 61.67% upside | $100.73 | TheFly | Previous targets (0) |
Joshua Spector UBS | 0% 0/2 | over 1 year ago | $128 91.61% upside | $99.42 | StreetInsider | Previous targets (1) |
Charles Neivert Piper Sandler | 50% 1/2 | over 1 year ago | $105 57.18% upside | $94.44 | StreetInsider | Previous targets (1) |
Lawrence Alexander Jefferies | 33.33% 1/3 | over 1 year ago | $125 87.12% upside | $97.5 | StreetInsider | Previous targets (2) |
Arun Viswanathan RBC Capital | 0% 0/1 | over 1 year ago | $100 49.70% upside | $96.02 | TheFly | Previous targets (0) |
Lawrence Alexander Jefferies | 33.33% 1/3 | over 1 year ago | $102 52.69% upside | $99.26 | StreetInsider | Previous targets (2) |
Vincent Andrews Morgan Stanley | 0% 0/2 | about 2 years ago | $115 72.15% upside | $85.41 | Benzinga | Previous targets (1) |
Ben Isaacson Scotiabank | 50% 1/2 | over 2 years ago | $90 34.73% upside | $79.03 | Benzinga | Previous targets (1) |
Kieran de Brun Mizuho Securities | 100% 1/1 | over 2 years ago | $84 25.74% upside | $80.28 | Benzinga | Previous targets (0) |
Charles Neivert Piper Sandler | 50% 1/2 | over 2 years ago | $99 48.20% upside | $82.41 | StreetInsider | Previous targets (1) |
Unknown Citigroup | N/A | almost 3 years ago | $90 34.73% upside | $86.33 | Benzinga | N/A |
Unknown Goldman Sachs | N/A | almost 3 years ago | $89 33.23% upside | $83.48 | Benzinga | N/A |
Mehdi Hosseini Susquehanna | 0% 0/1 | about 3 years ago | $108 61.67% upside | $79.55 | Benzinga | Previous targets (0) |
Joshua Spector UBS | 0% 0/2 | about 3 years ago | $108 61.67% upside | $79.13 | TheFly | Previous targets (1) |
Unknown Deutsche Bank | N/A | about 3 years ago | $95 42.21% upside | $82.9 | Benzinga | N/A |
Unknown Citigroup | N/A | about 3 years ago | $93 39.22% upside | $81.95 | Benzinga | N/A |
Michael Sison Wells Fargo | 50% 1/2 | about 3 years ago | $95 42.21% upside | $84.11 | TheFly | Previous targets (1) |
Michael Sison Wells Fargo | 50% 1/2 | about 3 years ago | $110 64.67% upside | $101.83 | Pulse 2.0 | Previous targets (1) |
Unknown Barclays | N/A | about 3 years ago | $110 64.67% upside | $94.06 | Benzinga | N/A |
Unknown UBS | N/A | about 3 years ago | $118 76.64% upside | $95.36 | Benzinga | N/A |
Unknown Wells Fargo | N/A | over 3 years ago | $125 87.12% upside | $102.67 | Benzinga | N/A |
Michael Leithead Barclays | 0% 0/1 | over 3 years ago | $120 79.64% upside | $102.67 | TheFly | Previous targets (0) |
John Roberts CFA UBS | 0% 0/1 | over 3 years ago | $141 111.07% upside | $117.33 | StreetInsider | Previous targets (0) |
Vincent Andrews Morgan Stanley | 0% 0/2 | over 3 years ago | $165 147.00% upside | $120.52 | StreetInsider | Previous targets (1) |
PJ Juvekar Citigroup | 0% 0/1 | over 3 years ago | $140 109.58% upside | $120.52 | StreetInsider | Previous targets (0) |
Steve Byrne Bank of America Securities | 0% 0/2 | over 3 years ago | $149 123.05% upside | $121.27 | StreetInsider | Previous targets (1) |
Paretosh Misra Berenberg Bank | 0% 0/1 | about 4 years ago | $150 124.55% upside | $114.42 | Investing | Previous targets (0) |
Ben Isaacson Scotiabank | 50% 1/2 | over 4 years ago | $145 117.06% upside | $116.66 | TheFly | Previous targets (1) |
Josh Silverstein Wolfe Research | 0% 0/1 | over 4 years ago | $154 130.53% upside | $123.53 | TheFly | Previous targets (0) |
Robert Koort Goldman Sachs | 0% 0/1 | over 4 years ago | $148 121.55% upside | $125.14 | TheFly | Previous targets (0) |
Matthew Blair Tudor Pickering | 100% 1/1 | over 4 years ago | $117 75.14% upside | $115.35 | StreetInsider | Previous targets (0) |
Eastman Chemical Company Financial Estimates
Eastman Chemical Company Revenue Estimates
Eastman Chemical Company EBITDA Estimates
Eastman Chemical Company Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | |
Revenue
% change YoY
| $10.47B N/A | $10.58B 0.99% | $9.21B -12.94% | Avg: $9.86B Low: $9.58B High: $10.09B avg. 7.12% | Avg: $10.44B Low: $9.99B High: $10.78B avg. 5.83% | Avg: $11.37B Low: $10.88B High: $11.74B avg. 8.92% | |
Net Income
% change YoY
| $857M N/A | $793M -7.46% | $894M 12.73% | Avg: $1.03B Low: $984.82M High: $1.17B avg. 15.71% | Avg: $1.08B Low: $1.07B High: $1.14B avg. 5.05% | Avg: $1.46B Low: $1.38B High: $1.52B avg. 34.62% | |
EBITDA
% change YoY
| $2.41B N/A | $1.73B -28.41% | $1.80B 4.39% | Avg: $1.87B Low: $1.82B High: $1.91B avg. 3.74% | Avg: $1.98B Low: $1.89B High: $2.04B avg. 5.83% | Avg: $2.16B Low: $2.06B High: $2.23B avg. 8.92% | |
EPS
% change YoY
| $6.35 N/A | $5.85 -7.87% | $7.54 28.88% | Avg: $8.79 Low: $8.25 High: $9.83 avg. 16.59% | Avg: $9.28 Low: $9 High: $9.56 avg. 5.58% | Avg: $12.25 Low: $11.57 High: $12.77 avg. 32.01% | |
Operating Expenses
% change YoY
| $1.04B N/A | $990M -5.62% | $966M -2.42% | Avg: $740.48M Low: $719.01M High: $757.52M avg. -23.34% | Avg: $783.72M Low: $749.91M High: $809.25M avg. 5.83% | Avg: $853.66M Low: $816.84M High: $881.48M avg. 8.92% | |
FAQ
What is Eastman Chemical Company stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 18.46% in 2025-2027.
We have gathered data from 10 analysts. Their low estimate is 984.82M, average is 1.03B and high is 1.17B.
What is Eastman Chemical Company stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 7.29% in 2025-2027.
We have gathered data from 14 analysts. Their low revenue estimate is $9.58B, average is $9.86B and high is $10.09B.
What is Eastman Chemical Company stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 18.06% in 2025-2027.
We have gathered data from 10 analysts. Their low earnings per share estimate is $8.25, average is $8.79 and high is $9.83.
What is the best performing analyst?
In the last twelve months 3 analysts have been covering Eastman Chemical Company stock. The most successful analyst is Aleksey Yefremov.